A PHASE 1-2 TRIAL OF DIETHYLSTILBESTROL PLUS LOW DOSE WARFARIN IN ADVANCED PROSTATE CARCINOMA
- 1 January 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (1) , 169-172
- https://doi.org/10.1016/s0022-5347(01)62089-5
Abstract
Conclusions The significant thromboembolic toxicity associated with the hypercoagulable state induced by diethylstilbestrol is not reduced by fixed low dose warfarin therapy.Keywords
This publication has 9 references indexed in Scilit:
- Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.Journal of Clinical Oncology, 1996
- The relationship between cardiovascular complications of estrogen therapy and fibrinolysis in patients with prostatic cancerThe Prostate, 1992
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous CathetersAnnals of Internal Medicine, 1990
- Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.Journal of Clinical Investigation, 1987
- Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.BMJ, 1987
- Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762Journal of Urology, 1986
- The veterans administration cooperative urological research group's studies of cancer of the prostateCancer, 1973
- Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic CarcinomaBMJ, 1971
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941